Author

W. M. Rabeh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:protein structure· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

J. C. Ferreira· 2 shared A. Cakir· 1 shared A. G. O. Demir· 1 shared A. J. Villanueva· 1 shared A. Mardinoglu· 1 shared B. E. Kerman· 1 shared E. Karakoc· 1 shared E. M. Ozdemir· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

J. C. Ferreira

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of Novel Allosteric Sites of SARS-CoV-2 Papain-Like Protease (PLpro) for the Development of COVID-19 Antivirals

J. C. Ferreira, K. Al Adem, S. Fadl, A. J. Villanueva, L. Alzyoud, M. A. Ghattas, W. M. Rabeh

This study identifies three potential allosteric sites on SARS-CoV-2 PLpro, evaluates their impact on proteolytic activity through alanine mutagenesis, and highlights Pockets 1 and 3 as promising targets for antiviral drug development.

bioRxiv · May 16, 2023Biochemistry

Hexokinase 1b is a novel target for non-small-cell lung cancer

Y. Yozgat, E. Karakoc, O. Sahin, S. Cimen, W. M. Rabeh, M. S. Aydin, A. Mardinoglu, I. Gursel, A. Cakir, O. Sensoy, E. M. Ozdemir, Y. Bayrak, M. Z. Gunluoglu, O. Saatci, J. Jabbar, , M. A. Cevher

This study identifies HK1b as a novel therapeutic target in NSCLC by showing its role in glycolysis, tumor progression, and cisplatin resistance.

bioRxiv · Jun 27, 2022 · PreprintCancer Biology